In the news
Toothful or toothless? Biden’s biosimilar bills under the microscope
April 28, 2021AMJC
Related news
In the news
May 5, 2022
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
Minneapolis/St. Paul Business Journal
In the news
May 5, 2022
Prime Therapeutics paying $1.35 billion for Magellan Health’s pharmacy business
Star Tribune